RB
Reticle Biosystems, Inc.
SEC filingManufacturing · San Francisco, CA
Amount raised$1Msold at filing
Total offering$1M
Investors in the raise1count reported to the SEC
FiledJul 14, 2026first sale Jun 8, 2026
Form D does not name the investors. If a news report names them, they appear here.
Named in the filing
James CheExecutive Officer, Director, Promoter
Executive officers, directors and promoters as listed on the Form D.